Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a maintenance update to the ClinicalTrials.gov page. No substantive study content appears to be altered.
    Difference
    0.0%
    Check dated 2026-08-08T23:00:26.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows revision v3.6.4 replacing v3.6.3, indicating a backend/software update rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-25T13:13:04.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.2 to v3.6.3, indicating a minor update to the page's template or content management while the study details remain the same.
    Difference
    0.0%
    Check dated 2026-07-04T03:50:51.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects a minor system-level update to the page.
    Difference
    0.0%
    Check dated 2026-06-26T23:12:08.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    New navigation/help links were added to guide eligibility, contact, reading the study record, common questions, and how to join; the Intervention/Treatment header formatting was updated, and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T13:43:25.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous v3.5.4 in the page footer, indicating a minor version update. This change appears to be a backend or CMS update and does not affect the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-05T10:10:56.000Z thumbnail image

Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.